PharmaceuticalMarketingServices
The constraint in pharma marketing is not creative. It is coordination: getting field, digital, medical and events to reach the same physician with the same message in one window, so the effect builds instead of colliding. Most cannot see they are failing at it, because each channel reports separately.
In short
Hibridge plans and delivers marketing programmes for prescription and consumer health brands across HCP and patient audiences. Work spans brand planning, omnichannel campaign design, detail aids and scientific materials, patient support and adherence programmes, KOL and medical education activity, and measurement that links spend to prescribing behaviour.
What we do
HCP and patient programmes that survive review and move prescribing.
Brand planning
Positioning, message architecture, lifecycle strategy and the annual brand plan, built to hold up in review, not be rewritten after it.
Omnichannel campaign design
Sequenced HCP journeys across field, email, web, closed-loop marketing and third-party media, timed so channels reinforce rather than duplicate.
HCP materials and detail aids
Scientific narrative, visual aids, leave-behinds and reprint carriers. Referenced, on-label and checked before they reach your reviewers.
Patient programmes
Adherence, education and support programmes designed inside local pharmacovigilance and data protection rules.
Medical education and KOL
Speaker programmes, standalone education, and advisory engagement with fair-market-value discipline throughout.
Measurement
A metric framework agreed up front, tied to prescribing and access outcomes rather than impressions.
Approach
How the work runs
- 01
Audit
What reaches your priority prescribers today, across every channel, in one view.
- 02
Plan
Message architecture and channel sequence, with compliance positions resolved during planning, not after.
- 03
Produce
Materials developed and checked by our compliance team before they go to your MLR process.
- 04
Measure
Monthly read against the agreed framework, with reallocation decisions made on evidence.
Why it matters
Synchronisation is the highest-impact and most often missed variable in pharma marketing. The measured uplift from getting it right is large, and most organisations are not close.
65%
65% of HCP engagements are not synchronised across channels.
60%
Within ten days, a rep meeting followed by a digital exposure is 30% more likely to result in a prescription. HCPs who also visit a brand website following a rep visit are 60% more likely to prescribe.
23%
Synchronising digital marketing with field engagement increases marketing effectiveness by 23%.
45%
Only 45% of healthcare professionals are accessible to biopharma companies, down from 60% eighteen months earlier. Half restrict engagement to three or fewer companies.
Every figure names its publisher. Where a figure is organiser-reported or secondary, we say so.
Frequently asked questions
Do you work on prescription brands, consumer health, or both?
Both. They run under different rules: promotional codes, claim substantiation and channel latitude all differ. We scope them separately even inside the same portfolio.
Can you work with our existing creative agency?
Yes. A common arrangement is that we hold strategy, coordination and the internal compliance check while the existing agency keeps execution.
How do you measure marketing effectiveness in a market with limited script data?
By agreeing a proxy hierarchy up front (sales-out, tender wins, engagement depth on owned channels, field-reported behaviour change) and stating the confidence level of each rather than implying precision we do not have.
Related services